Heparin or bivalirudin for non-primary PCI: Beware of neat and simple answers…

Key Points

• The debate regarding the choice of heparin or bivalirudin as the preferred anticoagulant in PCI is still ongoing
• Nonrandomized registry data are severely limited for comparative analyses and should therefore always be interpreted with caution
• Clinicians should resist simplistic data interpretations or populist cries relating to cost, but rather focus on valid benefit:risk analyses for their clinical decision making

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2xZh0Na
via IFTTT